Breast Cancer,HER2-,TNBC (Triple Negative Breast Cancer) Interim Analysis of Phase III SASCIA Trial on SG in High-Risk HER2-Negative BC Jun 30, 2023
Breast Cancer,Other Cancers Exposure-Response Model to Assess Veliparib Effects in BRCA-Mutated Advanced Breast Cancer Jun 23, 2023
Breast Cancer Denosumab’s Long-term Impact on Fracture Reduction and Survival in Breast Cancer Jun 23, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) PD-L1 Expression Predicts Efficacy of PD-1/PD-L1 Inhibitors in Metastatic TNBC Jun 15, 2023
Breast Cancer,TNBC (Triple Negative Breast Cancer) Residual Cancer Burden Impacts EFS in Neoadjuvant Pembrolizumab + Chemo for Early TNBC Jun 15, 2023
Breast Cancer Palbociclib Plus Letrozole Improves OS in ER+/HER2- Advanced Breast Cancer: PALOMA-2 Analysis Jun 09, 2023
Breast Cancer Germline BRCA1/2 and Predisposition Genes in High-Risk Early-Stage HR+/HER2- BC Patients Treated With ET Jun 09, 2023
Breast Cancer Trastuzumab Deruxtecan Outperforms Physician's Choice in HER2+ Metastatic Breast Cancer Jun 09, 2023
